Financials

  • Market Capitalization 3.39 M
  • Employee 29
  • Founded 2014
  • CEO N/A
  • Website www.calidibio.com
  • Headquarter Delaware, United States
  • FIGI BBG012QFCL84
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4995
PHGE
BiomX Inc. COmmon Stock
0.14 USD+7.69%+7.69%-22.22%-97.39%3.74 M USD
5000
SXTP
60 Degrees Pharmaceuticals, Inc. - Common Stock
1.03 USD-2.83%-8.85%-31.79%-26.43%3.62 M USD
5009
GLMD
Galmed Pharmaceuticals Ltd. - Ordinary Shares
4.08 USD-5.34%-0.73%+655.56%+223.81%3.36 M USD
5012
XRTX
XORTX Therapeutics Inc. - Common Shares
2.34 USD-4.49%+24.47%+13.59%+203.90%3.26 M USD

Frequently asked questions about Calidi Biotherapeutics, Inc.

What is the Calidi Biotherapeutics, Inc. stock price today?

The current price of Calidi Biotherapeutics, Inc. (CLDI) is 1.31. Over the past 24 hours, the stock has changed by 0.00%. Follow the CLDI chart for real-time price dynamics.

What is the stock ticker of Calidi Biotherapeutics, Inc.?

Calidi Biotherapeutics, Inc. trades under the ticker CLDI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Calidi Biotherapeutics, Inc. stock going up?

CLDI has changed by -0.76% over the last week, -19.63% over the last month, and +73.33% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Calidi Biotherapeutics, Inc.?

Calidi Biotherapeutics, Inc. currently has a market capitalization of 3.39 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Calidi Biotherapeutics, Inc. earnings last quarter?

Last quarter, Calidi Biotherapeutics, Inc. reported earnings of -2.94 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Calidi Biotherapeutics, Inc. net income for the last quarter?

Calidi Biotherapeutics, Inc. reported net income of -4.16 M for the last quarter. The previous quarter showed -4.11 M, which means net income changed by -1.27%.

How many employees does Calidi Biotherapeutics, Inc. have?

As of the latest available data, Calidi Biotherapeutics, Inc. has 29 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Calidi Biotherapeutics, Inc. stock?

You can buy Calidi Biotherapeutics, Inc. (CLDI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Calidi Biotherapeutics, Inc. stock?

Investing in Calidi Biotherapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CLDI chart and related analysis on metatrader.com as part of your research.

News